Screener
Taysha Gene Therapies, Inc. TSHA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344610
FAQ
- What is Taysha Gene Therapies, Inc.'s net income?
- Taysha Gene Therapies, Inc. (TSHA) reported net income of -$46.64M in Q2 2026.
- How has Taysha Gene Therapies, Inc.'s net income changed year-over-year?
- Taysha Gene Therapies, Inc.'s net income decreased by 73.5% year-over-year, from -$26.88M to -$46.64M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s net income?
- Over 3 years (2021 to 2025), Taysha Gene Therapies, Inc.'s net income has grown at a -14.5% compound annual growth rate (CAGR), from -$174.52M to -$109M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Taysha Gene Therapies, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude